Market closed·Syncing…
Market closed · Close · 19 Nov

GKB Ophthalmics Limited GKBshare price and chart

GKB Ophthalmics closed at ₹58.64 on 19 November 2026, down 1.06% on the day. The range since listing is ₹55.01 to ₹76.02.

₹58.64The price one share last traded at, in rupees.▼ 1.06% · ₹0.63
Low since listing ₹5517% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹76

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on GKB

Real prices, every charge counted. Pick one or write your own.

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
44Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
81.5%Near average
today 81.5%20d avg 75.4%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.▼ 7.1%1 monthHow much the share price has changed over the period.▼ 0.8%3 monthsHow much the share price has changed over the period.▼ 9.8%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.66.3%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹30 Cr19 NovP/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.6.0xlast 4 quarters, to Sept 2026Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 months

Against its sectorWhere this company ranks among similar companies on each measure.

Medical Equipment & Supplies · 16 peers · medians
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.6.05vs 37 median
Cheapest: GKB 6.05Priciest: TARSONS 215.39
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.3.21%vs 7.06% median
Lowest: MHHL -4.14%Highest: AVIENCE 17.16%
Revenue growthHow much sales grew in the latest quarter against the same quarter a year earlier.8.53%vs 20.84% median
Lowest: FABTECH -24.2%Highest: NURECA 55.08%

What the numbers sayShort plain statements about this company's latest figures.

Written by fixed rules

Latest quarterIn the quarter to September 2026 (results filed 12 Nov 2026), sales rose 8.5% from a year earlier to ₹32.7 cr and profit fell 33.9% to ₹1.2 cr.

Going well
  • No promoter shares were pledged at the end of December 2014.
Worth watching
  • Reported a loss in FY25.

Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.

Backtest idea · GKBMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on GKB
Backtest idea · GKBLower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on GKB
Backtest idea · GKBSupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on GKB
Your own ideaWrite a rule for GKB in plain English“Buy GKB when …”
Start writing
Buy the dip on GKBBuy when RSI(14) drops below 30
52-week high breakout on GKBBuy when closes at a 52-week high
Golden cross on GKBBuy when 50-day EMA crosses above 200-day
Stochastic oversold on GKBBuy when stochastic %K drops below 20
Pullback in an uptrend on GKBBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹30 cr
Larger than 6% of 16 peers
sector middle ₹560 cr
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.
6.0x
Lowest of 12 peers
sector middle 37.0x
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 38% of 16 peers
sector middle 0.0%
Sales growthHow much sales grew in the latest quarter against the same quarter a year earlier.
+8.5%
Lower than 78% of 9 peers
sector middle +20.8%

Peers are the listed companies in the exchange's own industry group: Medical Equipment & Supplies. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Revenue and profit, year by yearSales and net profit by financial year or by quarter.

Sales and net profit
FY25FY26
SalesNet profitfell vs last yearEach on its own scale · hover a bar for its figures
Op. marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax.5.6%FY26Profit YoYHow much net profit grew in the latest quarter against the same quarter a year earlier.▼ 33.9%latest quarterSalesMoney earned from selling the company's goods and services, before any costs. Also called revenue.₹149 CrFY26Net profitWhat is left for shareholders after all costs, interest and tax.₹3 CrFY26

Where every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.

FY26

In FY26, of every ₹100 of sales it kept ₹2.0 as profit. Other income added ₹1.5.

Where it wentPer ₹100 of sales
Running costs₹94.4Depreciation₹2.1Interest₹1.8Tax₹0.1Profit₹2.0Other items₹0.9

How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.

Compounded a year
3 years5 yearsLatest qtr
Sales--+8.5%
Profit--▼ 33.9%
3 and 5 years are compounded a year across full financial years. The latest quarter is against the same quarter a year earlier.

Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.

MeasureFY25FY26
Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax.-2.5%5.6%
Net marginOf every ₹100 of sales in the year, how much was left as profit after everything.-6.5%2.0%
Interest coverHow many times the company's profit before interest could pay its interest bill.-0.3x2.4x

Each row against this company's own usual level: green better, red worse, grey close to it.

Backtest idea · GKBStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on GKB
Backtest idea · GKBPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on GKB
Backtest idea · GKBBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on GKB
Backtest idea · GKB52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on GKB
Backtest idea · GKBGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on GKB
MACD momentum on GKBBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on GKBBuy when closes below the lower Bollinger band
Supertrend rider on GKBBuy when supertrend turns up
Buy the dip on GKBBuy when RSI(14) drops below 30
52-week high breakout on GKBBuy when closes at a 52-week high

Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.

Medical Equipment & Supplies
CompanyWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.How much operating profit the company made on all the money in the business, whether it came from owners or lenders.Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.Of every ₹100 of sales, how much is left as profit after all costs, interest and tax.How much sales grew in the latest quarter against the same quarter a year earlier.The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
MOLBIO
Molbio Diagnostics Limited
17,590 cr-12.2x--0.22--0.00%
POLYMED
Poly Medicure Limited
16,933 cr53.2x5.2x10.8%13.7%0.1214.8%+30.8%0.21%
TARSONS
Tarsons Products Limited
1,616 cr215.4x2.5x2.3%4.5%0.611.6%+20.8%0.00%
FISCHER
Fischer Medical Ventures Limited
1,496 cr87.9x3.2x8.1%11.5%0.114.3%+24.5%0.22%
LAXMIDENTL
Laxmi Dental Limited
1,060 cr32.7x4.0x12.8%13.1%0.0011.0%+10.0%0.00%
QLINE
Q-Line Biotech Limited
952 cr12.8x2.0x-19.5%0.2715.4%-0.00%
DENTALKART
Vasa Denticity Limited
840 cr69.7x4.4x-9.1%0.003.8%-0.00%
FABTECH
Fabtech Technologies Limited
593 cr15.7x1.4x9.1%11.3%0.079.2%-24.2%0.45%
OSELDEVICE
Osel Devices Limited
527 cr23.8x2.3x-23.9%0.649.5%-0.34%
QMSMEDI
QMS Medical Allied Services Limited
331 cr-3.6x--0.86--0.29%
NURECA
Nureca Limited
285 cr60.7x1.5x1.1%3.3%0.012.7%+55.1%0.00%
APRAMEYA
Aprameya Engineering Limited
238 cr-------0.00%
MADHAVBAUG
Vaidya Sane Ayurved Laboratories Limited
162 cr41.3x2.3x-16.9%0.183.4%+17.5%0.00%
AVIENCE
Avience Biomedicals Limited
138 cr12.2x2.2x-23.2%0.4417.2%-0.00%
MHHL
Mohini Health & Hygiene Limited
49 cr-0.5x--9.9%1.62-4.1%+50.2%0.00%
GKB
GKB Ophthalmics Limited
30 cr6.0x----3.2%+8.5%0.00%
GML
Galaxy Medicare Limited
26 cr8.7x0.6x-11.2%0.107.1%+7.8%4.15%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
·
·
·
·
·
·
·
·
-2.7
-9.4
+0.6
·
-11.3%
3m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

No bulk or block deals on record for GKB in the window we hold.

Read enough? Test GKB. “Buy GKB when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free